111, Inc. Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee
Key Highlights
- ➤111 (YI) special committee retains Houlihan Lokey China as independent financial advisor
- ➤Kirkland & Ellis appointed U.S. legal counsel for Proposal and strategic-alternatives review
- ➤Board cautions no decisions made and provides no assurance of a definitive transaction
- ➤Proposal review concerns preliminary, non-binding letter dated September 16, 2026
111, Inc. Announces Appointment of Independent Financial Advisor and Legal Counsel to the Special Committee PR Newswire
SHANGHAI, Oct. 26, 2026 /PRNewswire/ -- 111, Inc. ( "111" or the "Company") (NASDAQ: YI), a leading tech-enabled healthcare platform company in China, announced today that the special committee (the "Special Committee"), comprising three independent directors, Mr. Jian Sun, who is the chairman of the Special Committee, Mr. Nee Chuan Teo and Mr. Jun Luo, established by the Company's Board of Directors ("the Board"), has retained Houlihan Lokey China Limited as its independent financial advisor and Kirkland & Ellis as its U.S. legal counsel in connection with its review and evaluation of the previously announced preliminary, non-binding proposal letter dated September 16, 2026 (the "Proposal") as well as other potential strategic alternatives that the Company may pursue.
Get started
Create a free account to read the full story.